Concepedia

Lucien Gazi

LG

Statistics

Publications

18

Citations

929

H-Index

17

Active since

1998

Affiliations

Novartis (Switzerland)(Current)

University of Reading

Oxagen (United Kingdom)

Novartis (United States)

Princess Margaret Cancer Centre

Lucien Gazi is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and molecular pharmacology.

Top concepts

Publications per year

1998–2017

18

Publications

18

Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells

Luzheng Xue, Shân L. Gyles, Frank R. Wettey et al. · The Journal of Immunology · 2005 · 263 citations

, , +19

Functional coupling of the human dopamine D<sub>2</sub> receptor with Gα<sub>i1</sub>, Gα<sub>i2</sub>, Gα<sub>i3</sub> and Gα<sub>o</sub> G proteins: evidence for agonist regulation of G protein selectivity

Lucien Gazi, Sarah A. Nickolls, Philip G. Strange · British Journal of Pharmacology · 2003 · 94 citations · Full text

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

Guillermo Garcia‐Manero, Mikkael A. Sekeres, Miklós Egyed et al. · Leukemia · 2017 · 69 citations · Full text

Receptor density as a factor governing the efficacy of the dopamine D<sub>4</sub> receptor ligands, L‐745,870 and U‐101958 at human recombinant D<sub>4.4</sub> receptors expressed in CHO cells

Lucien Gazi, Ionel Bobirnac, M Danzeisen et al. · British Journal of Pharmacology · 1999 · 67 citations · Full text

Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils

Roy Pettipher, Shân L. Vinall, Luzheng Xue et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 65 citations

1–5 of 18